Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Specialty Breathable Membrane Market

ID: MRFR/CnM/27852-HCR
100 Pages
Sejal Akre
Last Updated: April 06, 2026

Specialty Breathable Membrane Market Research Report By Membrane Type (Polytetrafluoroethylene (PTFE), Polyvinylidene fluoride (PVDF), Polyethersulfone (PES), Polyurethane (PU), Polyethylene terephthalate (PET)), By Application (Medical, Protective Clothing, Construction, Automotive, Aerospace), By Pore Size (Micropores (0.1-10 m), Mesoporous (2-50 nm), Macroporous (>50 nm)), By Hydrophobicity (Hydrophobic, Hydrophilic, Amphiphilic), By Sterility (Sterile, Non-sterile) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Specialty Breathable Membrane Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Membrane Type (USD Billion)
  49.     4.1.1 Polytetrafluoroethylene (PTFE)
  50.     4.1.2 Polyvinylidene fluoride (PVDF)
  51.     4.1.3 Polyethersulfone (PES)
  52.     4.1.4 Polyurethane (PU)
  53.     4.1.5 Polyethylene terephthalate (PET)
  54.   4.2 Chemicals and Materials, BY Application (USD Billion)
  55.     4.2.1 Medical
  56.     4.2.2 Protective Clothing
  57.     4.2.3 Construction
  58.     4.2.4 Automotive
  59.     4.2.5 Aerospace
  60.   4.3 Chemicals and Materials, BY Pore Size (USD Billion)
  61.     4.3.1 Micropores (0.1-10 m)
  62.     4.3.2 Mesoporous (2-50 nm)
  63.     4.3.3 Macroporous (>50 nm)
  64.   4.4 Chemicals and Materials, BY Hydrophobicity (USD Billion)
  65.     4.4.1 Hydrophobic
  66.     4.4.2 Hydrophilic
  67.     4.4.3 Amphiphilic
  68.   4.5 Chemicals and Materials, BY Sterility (USD Billion)
  69.     4.5.1 Sterile
  70.     4.5.2 Non-sterile
  71.   4.6 Chemicals and Materials, BY Region (USD Billion)
  72.     4.6.1 North America
  73.       4.6.1.1 US
  74.       4.6.1.2 Canada
  75.     4.6.2 Europe
  76.       4.6.2.1 Germany
  77.       4.6.2.2 UK
  78.       4.6.2.3 France
  79.       4.6.2.4 Russia
  80.       4.6.2.5 Italy
  81.       4.6.2.6 Spain
  82.       4.6.2.7 Rest of Europe
  83.     4.6.3 APAC
  84.       4.6.3.1 China
  85.       4.6.3.2 India
  86.       4.6.3.3 Japan
  87.       4.6.3.4 South Korea
  88.       4.6.3.5 Malaysia
  89.       4.6.3.6 Thailand
  90.       4.6.3.7 Indonesia
  91.       4.6.3.8 Rest of APAC
  92.     4.6.4 South America
  93.       4.6.4.1 Brazil
  94.       4.6.4.2 Mexico
  95.       4.6.4.3 Argentina
  96.       4.6.4.4 Rest of South America
  97.     4.6.5 MEA
  98.       4.6.5.1 GCC Countries
  99.       4.6.5.2 South Africa
  100.       4.6.5.3 Rest of MEA
  101. 5 SECTION V: COMPETITIVE ANALYSIS
  102.   5.1 Competitive Landscape
  103.     5.1.1 Overview
  104.     5.1.2 Competitive Analysis
  105.     5.1.3 Market share Analysis
  106.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  107.     5.1.5 Competitive Benchmarking
  108.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  109.     5.1.7 Key developments and growth strategies
  110.       5.1.7.1 New Product Launch/Service Deployment
  111.       5.1.7.2 Merger & Acquisitions
  112.       5.1.7.3 Joint Ventures
  113.     5.1.8 Major Players Financial Matrix
  114.       5.1.8.1 Sales and Operating Income
  115.       5.1.8.2 Major Players R&D Expenditure. 2023
  116.   5.2 Company Profiles
  117.     5.2.1 Gore (US)
  118.       5.2.1.1 Financial Overview
  119.       5.2.1.2 Products Offered
  120.       5.2.1.3 Key Developments
  121.       5.2.1.4 SWOT Analysis
  122.       5.2.1.5 Key Strategies
  123.     5.2.2 3M (US)
  124.       5.2.2.1 Financial Overview
  125.       5.2.2.2 Products Offered
  126.       5.2.2.3 Key Developments
  127.       5.2.2.4 SWOT Analysis
  128.       5.2.2.5 Key Strategies
  129.     5.2.3 DuPont (US)
  130.       5.2.3.1 Financial Overview
  131.       5.2.3.2 Products Offered
  132.       5.2.3.3 Key Developments
  133.       5.2.3.4 SWOT Analysis
  134.       5.2.3.5 Key Strategies
  135.     5.2.4 Sioen Industries (BE)
  136.       5.2.4.1 Financial Overview
  137.       5.2.4.2 Products Offered
  138.       5.2.4.3 Key Developments
  139.       5.2.4.4 SWOT Analysis
  140.       5.2.4.5 Key Strategies
  141.     5.2.5 Mitsui Chemicals (JP)
  142.       5.2.5.1 Financial Overview
  143.       5.2.5.2 Products Offered
  144.       5.2.5.3 Key Developments
  145.       5.2.5.4 SWOT Analysis
  146.       5.2.5.5 Key Strategies
  147.     5.2.6 Asahi Kasei (JP)
  148.       5.2.6.1 Financial Overview
  149.       5.2.6.2 Products Offered
  150.       5.2.6.3 Key Developments
  151.       5.2.6.4 SWOT Analysis
  152.       5.2.6.5 Key Strategies
  153.     5.2.7 Trelleborg (SE)
  154.       5.2.7.1 Financial Overview
  155.       5.2.7.2 Products Offered
  156.       5.2.7.3 Key Developments
  157.       5.2.7.4 SWOT Analysis
  158.       5.2.7.5 Key Strategies
  159.     5.2.8 Saint-Gobain (FR)
  160.       5.2.8.1 Financial Overview
  161.       5.2.8.2 Products Offered
  162.       5.2.8.3 Key Developments
  163.       5.2.8.4 SWOT Analysis
  164.       5.2.8.5 Key Strategies
  165.     5.2.9 H.B. Fuller (US)
  166.       5.2.9.1 Financial Overview
  167.       5.2.9.2 Products Offered
  168.       5.2.9.3 Key Developments
  169.       5.2.9.4 SWOT Analysis
  170.       5.2.9.5 Key Strategies
  171.   5.3 Appendix
  172.     5.3.1 References
  173.     5.3.2 Related Reports
  174. 6 LIST OF FIGURES
  175.   6.1 MARKET SYNOPSIS
  176.   6.2 NORTH AMERICA MARKET ANALYSIS
  177.   6.3 US MARKET ANALYSIS BY MEMBRANE TYPE
  178.   6.4 US MARKET ANALYSIS BY APPLICATION
  179.   6.5 US MARKET ANALYSIS BY PORE SIZE
  180.   6.6 US MARKET ANALYSIS BY HYDROPHOBICITY
  181.   6.7 US MARKET ANALYSIS BY STERILITY
  182.   6.8 CANADA MARKET ANALYSIS BY MEMBRANE TYPE
  183.   6.9 CANADA MARKET ANALYSIS BY APPLICATION
  184.   6.10 CANADA MARKET ANALYSIS BY PORE SIZE
  185.   6.11 CANADA MARKET ANALYSIS BY HYDROPHOBICITY
  186.   6.12 CANADA MARKET ANALYSIS BY STERILITY
  187.   6.13 EUROPE MARKET ANALYSIS
  188.   6.14 GERMANY MARKET ANALYSIS BY MEMBRANE TYPE
  189.   6.15 GERMANY MARKET ANALYSIS BY APPLICATION
  190.   6.16 GERMANY MARKET ANALYSIS BY PORE SIZE
  191.   6.17 GERMANY MARKET ANALYSIS BY HYDROPHOBICITY
  192.   6.18 GERMANY MARKET ANALYSIS BY STERILITY
  193.   6.19 UK MARKET ANALYSIS BY MEMBRANE TYPE
  194.   6.20 UK MARKET ANALYSIS BY APPLICATION
  195.   6.21 UK MARKET ANALYSIS BY PORE SIZE
  196.   6.22 UK MARKET ANALYSIS BY HYDROPHOBICITY
  197.   6.23 UK MARKET ANALYSIS BY STERILITY
  198.   6.24 FRANCE MARKET ANALYSIS BY MEMBRANE TYPE
  199.   6.25 FRANCE MARKET ANALYSIS BY APPLICATION
  200.   6.26 FRANCE MARKET ANALYSIS BY PORE SIZE
  201.   6.27 FRANCE MARKET ANALYSIS BY HYDROPHOBICITY
  202.   6.28 FRANCE MARKET ANALYSIS BY STERILITY
  203.   6.29 RUSSIA MARKET ANALYSIS BY MEMBRANE TYPE
  204.   6.30 RUSSIA MARKET ANALYSIS BY APPLICATION
  205.   6.31 RUSSIA MARKET ANALYSIS BY PORE SIZE
  206.   6.32 RUSSIA MARKET ANALYSIS BY HYDROPHOBICITY
  207.   6.33 RUSSIA MARKET ANALYSIS BY STERILITY
  208.   6.34 ITALY MARKET ANALYSIS BY MEMBRANE TYPE
  209.   6.35 ITALY MARKET ANALYSIS BY APPLICATION
  210.   6.36 ITALY MARKET ANALYSIS BY PORE SIZE
  211.   6.37 ITALY MARKET ANALYSIS BY HYDROPHOBICITY
  212.   6.38 ITALY MARKET ANALYSIS BY STERILITY
  213.   6.39 SPAIN MARKET ANALYSIS BY MEMBRANE TYPE
  214.   6.40 SPAIN MARKET ANALYSIS BY APPLICATION
  215.   6.41 SPAIN MARKET ANALYSIS BY PORE SIZE
  216.   6.42 SPAIN MARKET ANALYSIS BY HYDROPHOBICITY
  217.   6.43 SPAIN MARKET ANALYSIS BY STERILITY
  218.   6.44 REST OF EUROPE MARKET ANALYSIS BY MEMBRANE TYPE
  219.   6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  220.   6.46 REST OF EUROPE MARKET ANALYSIS BY PORE SIZE
  221.   6.47 REST OF EUROPE MARKET ANALYSIS BY HYDROPHOBICITY
  222.   6.48 REST OF EUROPE MARKET ANALYSIS BY STERILITY
  223.   6.49 APAC MARKET ANALYSIS
  224.   6.50 CHINA MARKET ANALYSIS BY MEMBRANE TYPE
  225.   6.51 CHINA MARKET ANALYSIS BY APPLICATION
  226.   6.52 CHINA MARKET ANALYSIS BY PORE SIZE
  227.   6.53 CHINA MARKET ANALYSIS BY HYDROPHOBICITY
  228.   6.54 CHINA MARKET ANALYSIS BY STERILITY
  229.   6.55 INDIA MARKET ANALYSIS BY MEMBRANE TYPE
  230.   6.56 INDIA MARKET ANALYSIS BY APPLICATION
  231.   6.57 INDIA MARKET ANALYSIS BY PORE SIZE
  232.   6.58 INDIA MARKET ANALYSIS BY HYDROPHOBICITY
  233.   6.59 INDIA MARKET ANALYSIS BY STERILITY
  234.   6.60 JAPAN MARKET ANALYSIS BY MEMBRANE TYPE
  235.   6.61 JAPAN MARKET ANALYSIS BY APPLICATION
  236.   6.62 JAPAN MARKET ANALYSIS BY PORE SIZE
  237.   6.63 JAPAN MARKET ANALYSIS BY HYDROPHOBICITY
  238.   6.64 JAPAN MARKET ANALYSIS BY STERILITY
  239.   6.65 SOUTH KOREA MARKET ANALYSIS BY MEMBRANE TYPE
  240.   6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  241.   6.67 SOUTH KOREA MARKET ANALYSIS BY PORE SIZE
  242.   6.68 SOUTH KOREA MARKET ANALYSIS BY HYDROPHOBICITY
  243.   6.69 SOUTH KOREA MARKET ANALYSIS BY STERILITY
  244.   6.70 MALAYSIA MARKET ANALYSIS BY MEMBRANE TYPE
  245.   6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION
  246.   6.72 MALAYSIA MARKET ANALYSIS BY PORE SIZE
  247.   6.73 MALAYSIA MARKET ANALYSIS BY HYDROPHOBICITY
  248.   6.74 MALAYSIA MARKET ANALYSIS BY STERILITY
  249.   6.75 THAILAND MARKET ANALYSIS BY MEMBRANE TYPE
  250.   6.76 THAILAND MARKET ANALYSIS BY APPLICATION
  251.   6.77 THAILAND MARKET ANALYSIS BY PORE SIZE
  252.   6.78 THAILAND MARKET ANALYSIS BY HYDROPHOBICITY
  253.   6.79 THAILAND MARKET ANALYSIS BY STERILITY
  254.   6.80 INDONESIA MARKET ANALYSIS BY MEMBRANE TYPE
  255.   6.81 INDONESIA MARKET ANALYSIS BY APPLICATION
  256.   6.82 INDONESIA MARKET ANALYSIS BY PORE SIZE
  257.   6.83 INDONESIA MARKET ANALYSIS BY HYDROPHOBICITY
  258.   6.84 INDONESIA MARKET ANALYSIS BY STERILITY
  259.   6.85 REST OF APAC MARKET ANALYSIS BY MEMBRANE TYPE
  260.   6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION
  261.   6.87 REST OF APAC MARKET ANALYSIS BY PORE SIZE
  262.   6.88 REST OF APAC MARKET ANALYSIS BY HYDROPHOBICITY
  263.   6.89 REST OF APAC MARKET ANALYSIS BY STERILITY
  264.   6.90 SOUTH AMERICA MARKET ANALYSIS
  265.   6.91 BRAZIL MARKET ANALYSIS BY MEMBRANE TYPE
  266.   6.92 BRAZIL MARKET ANALYSIS BY APPLICATION
  267.   6.93 BRAZIL MARKET ANALYSIS BY PORE SIZE
  268.   6.94 BRAZIL MARKET ANALYSIS BY HYDROPHOBICITY
  269.   6.95 BRAZIL MARKET ANALYSIS BY STERILITY
  270.   6.96 MEXICO MARKET ANALYSIS BY MEMBRANE TYPE
  271.   6.97 MEXICO MARKET ANALYSIS BY APPLICATION
  272.   6.98 MEXICO MARKET ANALYSIS BY PORE SIZE
  273.   6.99 MEXICO MARKET ANALYSIS BY HYDROPHOBICITY
  274.   6.100 MEXICO MARKET ANALYSIS BY STERILITY
  275.   6.101 ARGENTINA MARKET ANALYSIS BY MEMBRANE TYPE
  276.   6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION
  277.   6.103 ARGENTINA MARKET ANALYSIS BY PORE SIZE
  278.   6.104 ARGENTINA MARKET ANALYSIS BY HYDROPHOBICITY
  279.   6.105 ARGENTINA MARKET ANALYSIS BY STERILITY
  280.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY MEMBRANE TYPE
  281.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  282.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PORE SIZE
  283.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY HYDROPHOBICITY
  284.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY STERILITY
  285.   6.111 MEA MARKET ANALYSIS
  286.   6.112 GCC COUNTRIES MARKET ANALYSIS BY MEMBRANE TYPE
  287.   6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  288.   6.114 GCC COUNTRIES MARKET ANALYSIS BY PORE SIZE
  289.   6.115 GCC COUNTRIES MARKET ANALYSIS BY HYDROPHOBICITY
  290.   6.116 GCC COUNTRIES MARKET ANALYSIS BY STERILITY
  291.   6.117 SOUTH AFRICA MARKET ANALYSIS BY MEMBRANE TYPE
  292.   6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  293.   6.119 SOUTH AFRICA MARKET ANALYSIS BY PORE SIZE
  294.   6.120 SOUTH AFRICA MARKET ANALYSIS BY HYDROPHOBICITY
  295.   6.121 SOUTH AFRICA MARKET ANALYSIS BY STERILITY
  296.   6.122 REST OF MEA MARKET ANALYSIS BY MEMBRANE TYPE
  297.   6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION
  298.   6.124 REST OF MEA MARKET ANALYSIS BY PORE SIZE
  299.   6.125 REST OF MEA MARKET ANALYSIS BY HYDROPHOBICITY
  300.   6.126 REST OF MEA MARKET ANALYSIS BY STERILITY
  301.   6.127 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  302.   6.128 RESEARCH PROCESS OF MRFR
  303.   6.129 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  304.   6.130 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  305.   6.131 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  306.   6.132 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  307.   6.133 CHEMICALS AND MATERIALS, BY MEMBRANE TYPE, 2024 (% SHARE)
  308.   6.134 CHEMICALS AND MATERIALS, BY MEMBRANE TYPE, 2024 TO 2035 (USD Billion)
  309.   6.135 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
  310.   6.136 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Billion)
  311.   6.137 CHEMICALS AND MATERIALS, BY PORE SIZE, 2024 (% SHARE)
  312.   6.138 CHEMICALS AND MATERIALS, BY PORE SIZE, 2024 TO 2035 (USD Billion)
  313.   6.139 CHEMICALS AND MATERIALS, BY HYDROPHOBICITY, 2024 (% SHARE)
  314.   6.140 CHEMICALS AND MATERIALS, BY HYDROPHOBICITY, 2024 TO 2035 (USD Billion)
  315.   6.141 CHEMICALS AND MATERIALS, BY STERILITY, 2024 (% SHARE)
  316.   6.142 CHEMICALS AND MATERIALS, BY STERILITY, 2024 TO 2035 (USD Billion)
  317.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  318. 7 LIST OF TABLES
  319.   7.1 LIST OF ASSUMPTIONS
  320.     7.1.1
  321.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  322.     7.2.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  323.     7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  324.     7.2.3 BY PORE SIZE, 2025-2035 (USD Billion)
  325.     7.2.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  326.     7.2.5 BY STERILITY, 2025-2035 (USD Billion)
  327.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  328.     7.3.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  329.     7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  330.     7.3.3 BY PORE SIZE, 2025-2035 (USD Billion)
  331.     7.3.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  332.     7.3.5 BY STERILITY, 2025-2035 (USD Billion)
  333.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  334.     7.4.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  335.     7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  336.     7.4.3 BY PORE SIZE, 2025-2035 (USD Billion)
  337.     7.4.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  338.     7.4.5 BY STERILITY, 2025-2035 (USD Billion)
  339.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  340.     7.5.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  341.     7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  342.     7.5.3 BY PORE SIZE, 2025-2035 (USD Billion)
  343.     7.5.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  344.     7.5.5 BY STERILITY, 2025-2035 (USD Billion)
  345.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  346.     7.6.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  347.     7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  348.     7.6.3 BY PORE SIZE, 2025-2035 (USD Billion)
  349.     7.6.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  350.     7.6.5 BY STERILITY, 2025-2035 (USD Billion)
  351.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  352.     7.7.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  353.     7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  354.     7.7.3 BY PORE SIZE, 2025-2035 (USD Billion)
  355.     7.7.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  356.     7.7.5 BY STERILITY, 2025-2035 (USD Billion)
  357.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  358.     7.8.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  359.     7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  360.     7.8.3 BY PORE SIZE, 2025-2035 (USD Billion)
  361.     7.8.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  362.     7.8.5 BY STERILITY, 2025-2035 (USD Billion)
  363.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  364.     7.9.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  365.     7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  366.     7.9.3 BY PORE SIZE, 2025-2035 (USD Billion)
  367.     7.9.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  368.     7.9.5 BY STERILITY, 2025-2035 (USD Billion)
  369.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  370.     7.10.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  371.     7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  372.     7.10.3 BY PORE SIZE, 2025-2035 (USD Billion)
  373.     7.10.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  374.     7.10.5 BY STERILITY, 2025-2035 (USD Billion)
  375.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  376.     7.11.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  377.     7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  378.     7.11.3 BY PORE SIZE, 2025-2035 (USD Billion)
  379.     7.11.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  380.     7.11.5 BY STERILITY, 2025-2035 (USD Billion)
  381.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  382.     7.12.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  383.     7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  384.     7.12.3 BY PORE SIZE, 2025-2035 (USD Billion)
  385.     7.12.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  386.     7.12.5 BY STERILITY, 2025-2035 (USD Billion)
  387.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  388.     7.13.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  389.     7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  390.     7.13.3 BY PORE SIZE, 2025-2035 (USD Billion)
  391.     7.13.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  392.     7.13.5 BY STERILITY, 2025-2035 (USD Billion)
  393.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  394.     7.14.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  395.     7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  396.     7.14.3 BY PORE SIZE, 2025-2035 (USD Billion)
  397.     7.14.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  398.     7.14.5 BY STERILITY, 2025-2035 (USD Billion)
  399.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  400.     7.15.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  401.     7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  402.     7.15.3 BY PORE SIZE, 2025-2035 (USD Billion)
  403.     7.15.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  404.     7.15.5 BY STERILITY, 2025-2035 (USD Billion)
  405.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  406.     7.16.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  407.     7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  408.     7.16.3 BY PORE SIZE, 2025-2035 (USD Billion)
  409.     7.16.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  410.     7.16.5 BY STERILITY, 2025-2035 (USD Billion)
  411.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  412.     7.17.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  413.     7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  414.     7.17.3 BY PORE SIZE, 2025-2035 (USD Billion)
  415.     7.17.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  416.     7.17.5 BY STERILITY, 2025-2035 (USD Billion)
  417.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  418.     7.18.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  419.     7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  420.     7.18.3 BY PORE SIZE, 2025-2035 (USD Billion)
  421.     7.18.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  422.     7.18.5 BY STERILITY, 2025-2035 (USD Billion)
  423.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  424.     7.19.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  425.     7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  426.     7.19.3 BY PORE SIZE, 2025-2035 (USD Billion)
  427.     7.19.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  428.     7.19.5 BY STERILITY, 2025-2035 (USD Billion)
  429.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  430.     7.20.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  431.     7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  432.     7.20.3 BY PORE SIZE, 2025-2035 (USD Billion)
  433.     7.20.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  434.     7.20.5 BY STERILITY, 2025-2035 (USD Billion)
  435.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  436.     7.21.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  437.     7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  438.     7.21.3 BY PORE SIZE, 2025-2035 (USD Billion)
  439.     7.21.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  440.     7.21.5 BY STERILITY, 2025-2035 (USD Billion)
  441.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  442.     7.22.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  443.     7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  444.     7.22.3 BY PORE SIZE, 2025-2035 (USD Billion)
  445.     7.22.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  446.     7.22.5 BY STERILITY, 2025-2035 (USD Billion)
  447.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  448.     7.23.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  449.     7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  450.     7.23.3 BY PORE SIZE, 2025-2035 (USD Billion)
  451.     7.23.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  452.     7.23.5 BY STERILITY, 2025-2035 (USD Billion)
  453.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  454.     7.24.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  455.     7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  456.     7.24.3 BY PORE SIZE, 2025-2035 (USD Billion)
  457.     7.24.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  458.     7.24.5 BY STERILITY, 2025-2035 (USD Billion)
  459.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  460.     7.25.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  461.     7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  462.     7.25.3 BY PORE SIZE, 2025-2035 (USD Billion)
  463.     7.25.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  464.     7.25.5 BY STERILITY, 2025-2035 (USD Billion)
  465.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  466.     7.26.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  467.     7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  468.     7.26.3 BY PORE SIZE, 2025-2035 (USD Billion)
  469.     7.26.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  470.     7.26.5 BY STERILITY, 2025-2035 (USD Billion)
  471.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  472.     7.27.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  473.     7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  474.     7.27.3 BY PORE SIZE, 2025-2035 (USD Billion)
  475.     7.27.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  476.     7.27.5 BY STERILITY, 2025-2035 (USD Billion)
  477.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  478.     7.28.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  479.     7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  480.     7.28.3 BY PORE SIZE, 2025-2035 (USD Billion)
  481.     7.28.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  482.     7.28.5 BY STERILITY, 2025-2035 (USD Billion)
  483.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  484.     7.29.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  485.     7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  486.     7.29.3 BY PORE SIZE, 2025-2035 (USD Billion)
  487.     7.29.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  488.     7.29.5 BY STERILITY, 2025-2035 (USD Billion)
  489.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  490.     7.30.1 BY MEMBRANE TYPE, 2025-2035 (USD Billion)
  491.     7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  492.     7.30.3 BY PORE SIZE, 2025-2035 (USD Billion)
  493.     7.30.4 BY HYDROPHOBICITY, 2025-2035 (USD Billion)
  494.     7.30.5 BY STERILITY, 2025-2035 (USD Billion)
  495.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  496.     7.31.1
  497.   7.32 ACQUISITION/PARTNERSHIP
  498.     7.32.1

Chemicals and Materials Market Segmentation

Chemicals and Materials By Membrane Type (USD Billion, 2025-2035)

  • Polytetrafluoroethylene (PTFE)
  • Polyvinylidene fluoride (PVDF)
  • Polyethersulfone (PES)
  • Polyurethane (PU)
  • Polyethylene terephthalate (PET)

Chemicals and Materials By Application (USD Billion, 2025-2035)

  • Medical
  • Protective Clothing
  • Construction
  • Automotive
  • Aerospace

Chemicals and Materials By Pore Size (USD Billion, 2025-2035)

  • Micropores (0.1-10 m)
  • Mesoporous (2-50 nm)
  • Macroporous (>50 nm)

Chemicals and Materials By Hydrophobicity (USD Billion, 2025-2035)

  • Hydrophobic
  • Hydrophilic
  • Amphiphilic

Chemicals and Materials By Sterility (USD Billion, 2025-2035)

  • Sterile
  • Non-sterile

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions